Five things for pharma marketers to know: Thursday, August 17, 2017

Express Scripts to limit opioid coverage; Novo's diabetes drug lowers glucose levels in trial; startup aims to give doctors access to a patient's total costs

Frazier's call earns him praise, rare for a pharma CEO

It's not often that pharmaceutical companies are held up as examples of morality or leadership to the general public.

PhRMA criticizes the FDA's research into drug advertising and promotion

PhRMA criticizes the FDA's research into drug advertising and promotion

The lobbying group said it's unclear what the agency's goal is with this research and how it promotes public health.

Biogen, Merck use predictive modeling to better negotiate value-based contracts

Biogen, Merck use predictive modeling to better negotiate value-based contracts

What's holding back value-based pricing deals from moving beyond the pilot phase?

6 Campaigns That Celebrate the Union of Copy and Art

6 Campaigns That Celebrate the Union of Copy and Art

The copywriter and the art director come together to inform, spark hope, and create a path forward.

Study: Hiking the prices of heart drugs led to fewer sales

Study: Hiking the prices of heart drugs led to fewer sales

Prescription rates dramatically decreased following the price hikes of Valeant's Isuprel and Nitropress in 47 hospitals.

Johnson & Johnson in breach of U.K. rules over Nicorette marketing

Johnson & Johnson in breach of U.K. rules over Nicorette marketing

Johnson & Johnson has breached the U.K.'s drug regulation code in three places in promotions for smoking cessation product Nicorette.

Five things for pharma marketers to know: Wednesday, August 16, 2017

Five things for pharma marketers to know: Wednesday, August 16, 2017

Gottlieb criticizes drugmakers for 'gaming the system' on generics; investors ignore Trump's pharma criticism; docs are more supportive of single payer

W2O's Sentient adds Spitz, Viola to leadership team

W2O's Sentient adds Spitz, Viola to leadership team

Both positions were newly created as the agency has grown over the past year.

Five things for pharma marketers to know: Tuesday, August 15, 2017

Five things for pharma marketers to know: Tuesday, August 15, 2017

Pfizer accuses J&J of limiting biosimilar uptake; Trump again criticizes high drug prices; WebMD to reposition site to help consumers manage their health

Five things for pharma marketers to know: Monday, August 14, 2017

Five things for pharma marketers to know: Monday, August 14, 2017

Merck CEO leaves Trump's manufacturing council over Charlottesville response; researchers struggle to fill clinical trials for IO drugs; Roche shareholders sue over top-line results

Former Cleveland Clinic comms exec Angela Calman joins IBM Watson Health

Former Cleveland Clinic comms exec Angela Calman joins IBM Watson Health

Calman is joining the technology company as VP of comms for Watson Health.

Bill to allow imported drugs from Canada aims to create competition

Bill to allow imported drugs from Canada aims to create competition

The Congressional Budget Office says that Sanders' bill would save the U.S. federal government nearly $7 billion over the next decade.

Point-of-care group rolls out guidelines

Point-of-care group rolls out guidelines

The goal is to further cement point of care as a mainstream media channel.

Top 25 oncology brands in 2016, based on U.S. sales

Top 25 oncology brands in 2016, based on U.S. sales

Celgene's Revlimid tops the list, according to data compiled by EvaluatePharma.

Five things for pharma marketers to know: Friday, August 11, 2017

Five things for pharma marketers to know: Friday, August 11, 2017

Egalet slashes workforce in favor of opioid education; Novo's experimental obesity drug reports positive results; Trump declares opioid crisis a national emergency

Five things for pharma marketers to know: Thursday, August 10, 2017

Five things for pharma marketers to know: Thursday, August 10, 2017

One in 12 docs took payments from opioid makers; hospitals cut use of Isuprel and Nitropress after price hikes; AI helping develop ALS drugs

Infographic | What patients want: a better healthcare experience

Infographic | What patients want: a better healthcare experience

Patients are demanding more of their healthcare experience — and that includes from their healthcare providers, according to two new surveys.

A day at work with Makovsky's Rob Schachter

A day at work with Makovsky's Rob Schachter

A mentor once told him to keep learning and stay out of his comfort zone.

Five things for pharma marketers to know: Wednesday, August 9, 2017

Five things for pharma marketers to know: Wednesday, August 9, 2017

The FDA on pace for record generic drug approvals; CVS Health CEO doubts Amazon's entrance to pharmacy market; Sanofi to develop cancer immunotherapy